Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameConcord HC GP
Stock Code02453
Company Full NameTo be extracted
Industry醫療保健
Principal Activities公司為中國一家腫瘤醫療服務提供商,為癌癥患者及第三方醫療機構提供服務。
Listing Date2024-01-09
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市朝陽區光華路7號漢威大廈東區26A1–26A5室
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.concordmedical.com/
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 14.28 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 56,294,616

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 400,000 HK$ 5,712,000
4 lots 1,971,000 HK$ 28,145,880

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway None
Avg Daily HK Mkt Cap ---
Est. Threshold ---
Analysis Result 无法确定入通路径

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 11.08
First Day OpenHK$ 9.8
First Day Change-22.41%
First Day Volume3770200.0
First Day Turnover40455200.0
Use of Proceeds
1、約59.4%(即299.0百萬港元)用于償還部分計息銀行貸款; 2、約30.6%(即153.7百萬港元)用于為上海醫院的籌建提供資金,預計其將于2026年1月開始運營; 3、約10.0%(即50.3百萬港元)用作營運資金及其他一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 海通国际资本有限公司 CE ADQ859
Overall Coordinators (4)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 海通国际证券有限公司 CE AAF806 CLSA LIMITED CE AAB893 SPDB International Capital Limited CE BFZ375
Joint Bookrunners (14)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 海通国际证券有限公司 CE AAF806 CLSA LIMITED CE AAB893 SPDB International Capital Limited CE BFZ375 农银国际证券有限公司 CE ACX411 建银国际金融有限公司 CE AJO225 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 招银国际融资有限公司 CE AVM940 Fosun International Securities Limited CE AAF432 富途证券国际(香港)有限公司 CE AZT137 Livermore Holdings Limited CE BJN764 MOUETTE SECURITIES COMPANY LIMITED CE BLE877 VALUABLE CAPITAL LIMITED CE AUL711 老虎证券(香港)环球有限公司 CE BMU940
Joint Lead Managers (14)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 海通国际证券有限公司 CE AAF806 CLSA LIMITED CE AAB893 SPDB International Capital Limited CE BFZ375 农银国际证券有限公司 CE ACX411 建银国际金融有限公司 CE AJO225 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 招银国际融资有限公司 CE AVM940 Fosun International Securities Limited CE AAF432 富途证券国际(香港)有限公司 CE AZT137 Livermore Holdings Limited CE BJN764 MOUETTE SECURITIES COMPANY LIMITED CE BLE877 VALUABLE CAPITAL LIMITED CE AUL711 老虎证券(香港)环球有限公司 CE BMU940

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman楊建宇—
Company Secretary潘立臣;何詠雅—
No director data available.

Major Shareholders

Major Shareholders & Holdings醫學之星(上海)融資租賃有限公司(26.84%);中金佳泰貳期(天津)股權投資基金合伙企業(有限合伙)(16.75%);寧波信鈺嘉慧企業管理有限公司(10.86%);北京泰和誠醫療技術有限公司(9.55%)
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
Underlying data failed quality checks; AI interpretation downgraded and shown for reference only.

Market Sentiment

The IPO recorded a modest oversubscription ratio of 1.99 times, with a 100% hit rate indicating all applicants received full allocations. This lack of competitive demand suggests tepid market enthusiasm. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

No tier-level subscription data is available, making anomaly analysis impossible. With a 100% hit rate, allocation is uniform across all applicant sizes, obviating any tier-based efficiency concerns. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic data shows zero registered holders, which likely indicates incomplete reporting or a dispersed retail base. No patterns regarding mainland participation, gender, or age distribution can be discerned. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows Concord HC GP (02453) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect